Inflamalps SA is a prominent brand in the biotech and pharmaceutical industry. With a strong focus on therapeutic solutions, Inflamalps is dedicated to developing innovative treatments for various medical conditions. Heading this dynamic organization is Dr.

Vincent Mutel, a highly experienced biochemist and pharmacologist. As the Chairman, CEO, and co-founder, Dr. Mutel has played a pivotal role in bringing numerous R&D projects from discovery to advanced clinical trials.

Throughout his career, he has led Addex Pharmaceuticals Ltd to impressive growth, securing substantial venture financing and signing significant drug development partnerships. Joining Dr. Mutel is Dr.

Philippe Meuwly, the co-founder and CEO of Pharmalp SA. With extensive experience in the biopharmaceutical industry, Dr. Meuwly has successfully developed and commercialized natural medication, contributing significantly to the growth and success of OM Pharma.

Completing the Board of Directors are Mr. Levon Khachaturyan, a seasoned professional in private equity and M&A deals, and Mr. Oleg Sharonov, an expert in the financial sector.

Together, this exceptional team leads Inflamalps in its pursuit of groundbreaking advancements in the field of biotechnology and pharmaceuticals. Contact Inflamalps today to learn more about their projects and future developments